{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T18:02:05Z","timestamp":1789840925242,"version":"4.0.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,19]]},"DOI":"10.7759\/cureus.116548","type":"journal-article","created":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T17:15:40Z","timestamp":1789838140000},"source":"Crossref","is-referenced-by-count":0,"title":["Etanercept-Induced Cutaneous Necrotizing Vasculitis in a Patient With Rheumatoid Arthritis: A Case Report and Literature Review"],"prefix":"10.7759","author":[{"given":"Chaimae","family":"Nouri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Latifa","family":"Tahiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanan","family":"Rkain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatine","family":"Kronbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadoua","family":"Allali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-223356","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update","volume":"82","author":"Smolen JS","year":"2023","unstructured":"Smolen JS, Landew\u00e9 RB, Bergstra SA, et al.. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update. Ann Rheum Dis. 2023, 82:3-18. 10.1136\/ard-2022-223356","journal-title":"Ann Rheum Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0b013e3181441a68","article-title":"Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases","volume":"86","author":"Ramos-Casals M","year":"2007","unstructured":"Ramos-Casals M, Brito-Zer\u00f3n P, Mu\u00f1oz S, et al.. Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases. Medicine (Baltimore). 2007, 86:242-51. 10.1097\/MD.0b013e3181441a68","journal-title":"Medicine (Baltimore)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2012.04.011","article-title":"Vasculitis associated with tumor necrosis factor-\u03b1 inhibitors","volume":"87","author":"Sokumbi O","year":"2012","unstructured":"Sokumbi O, Wetter DA, Makol A, Warrington KJ. Vasculitis associated with tumor necrosis factor-\u03b1 inhibitors. Mayo Clin Proc. 2012, 87:739-45. 10.1016\/j.mayocp.2012.04.011","journal-title":"Mayo Clin Proc"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780380107","article-title":"Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis","volume":"38","author":"Prevoo ML","year":"1995","unstructured":"Prevoo ML, van 't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995, 38:44-8. 10.1002\/art.1780380107","journal-title":"Arthritis Rheum"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2006.02.010","article-title":"Vasculitides induced by TNFalpha antagonists: a study in 39 patients in France","volume":"73","author":"Saint Marcoux B","year":"2006","unstructured":"Saint Marcoux B, De Bandt M. Vasculitides induced by TNFalpha antagonists: a study in 39 patients in France. Joint Bone Spine. 2006, 73:710-3. 10.1016\/j.jbspin.2006.02.010","journal-title":"Joint Bone Spine"},{"key":"ref6","article-title":"Leukocytoclastic vasculitis associated with tumor necrosis factor-alpha blocking agents","volume":"31","author":"Mohan N","year":"2004","unstructured":"Mohan N, Edwards ET, Cupps TR, Slifman N, Lee JH, Siegel JN, Braun MM. Leukocytoclastic vasculitis associated with tumor necrosis factor-alpha blocking agents. J Rheumatol. 2004, 31:1955-8.","journal-title":"J Rheumatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1080\/00325481.2026.2696097","article-title":"Anti-TNF-induced vasculitis: analysis of data from the French national pharmacovigilance database","volume":"138","author":"Izquierdo F","year":"2026","unstructured":"Izquierdo F, Gourier G, Clabecq C, et al.. Anti-TNF-induced vasculitis: analysis of data from the French national pharmacovigilance database. Postgrad Med. 2026, 138:736-50. 10.1080\/00325481.2026.2696097","journal-title":"Postgrad Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-014-0076-6","article-title":"A practical approach to the diagnosis, evaluation, and management of cutaneous small-vessel vasculitis","volume":"15","author":"Goeser MR","year":"2014","unstructured":"Goeser MR, Laniosz V, Wetter DA. A practical approach to the diagnosis, evaluation, and management of cutaneous small-vessel vasculitis. Am J Clin Dermatol. 2014, 15:299-306. 10.1007\/s40257-014-0076-6","journal-title":"Am J Clin Dermatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.70249","article-title":"Recommendations for the diagnostic work-up of cutaneous small vessel vasculitis - Position Statement of the European Academy of Dermatology and Venereology Vasculitis and Vasculopathy Task Force","volume":"40","author":"Alpsoy E","year":"2026","unstructured":"Alpsoy E, Caproni M, Wetter DA, et al.. Recommendations for the diagnostic work-up of cutaneous small vessel vasculitis - Position Statement of the European Academy of Dermatology and Venereology Vasculitis and Vasculopathy Task Force. J Eur Acad Dermatol Venereol. 2026, 40:946-62. 10.1111\/jdv.70249","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref10","article-title":"Leukocytoclastic vasculitis due to etanercept","volume":"27","author":"Galaria NA","year":"2000","unstructured":"Galaria NA, Werth VP, Schumacher HR. Leukocytoclastic vasculitis due to etanercept. J Rheumatol. 2000, 27:2041-4.","journal-title":"J Rheumatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.5414\/cnp62234","article-title":"Antineutrophil cytoplasmic antibody-associated necrotizing crescentic glomerulonephritis in a patient receiving treatment with etanercept for severe rheumatoid arthritis","volume":"62","author":"Doulton TW","year":"2004","unstructured":"Doulton TW, Tucker B, Reardon J, Velasco N. Antineutrophil cytoplasmic antibody-associated necrotizing crescentic glomerulonephritis in a patient receiving treatment with etanercept for severe rheumatoid arthritis. Clin Nephrol. 2004, 62:234-8. 10.5414\/cnp62234","journal-title":"Clin Nephrol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfh832","article-title":"Development of glomerulonephritis during anti-TNF-alpha therapy for rheumatoid arthritis","volume":"20","author":"Stokes MB","year":"2005","unstructured":"Stokes MB, Foster K, Markowitz GS, et al.. Development of glomerulonephritis during anti-TNF-alpha therapy for rheumatoid arthritis. Nephrol Dial Transplant. 2005, 20:1400-6. 10.1093\/ndt\/gfh832","journal-title":"Nephrol Dial Transplant"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/art.37715","article-title":"2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides","volume":"65","author":"Jennette JC","year":"2013","unstructured":"Jennette JC, Falk RJ, Bacon PA, et al.. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013, 65:1-11. 10.1002\/art.37715","journal-title":"Arthritis Rheum"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/art.40375","article-title":"Nomenclature of cutaneous vasculitis: dermatologic addendum to the 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides","volume":"70","author":"Sunderk\u00f6tter CH","year":"2018","unstructured":"Sunderk\u00f6tter CH, Zelger B, Chen KR, et al.. Nomenclature of cutaneous vasculitis: dermatologic addendum to the 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheumatol. 2018, 70:171-84. 10.1002\/art.40375","journal-title":"Arthritis Rheumatol"},{"key":"ref15","article-title":"Drug-induced cutaneous vasculitides","volume":"150","author":"Antiga E","year":"2015","unstructured":"Antiga E, Verdelli A, Bonciani D, et al.. Drug-induced cutaneous vasculitides. G Ital Dermatol Venereol. 2015, 150:203-10.","journal-title":"G Ital Dermatol Venereol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ket475","article-title":"Vasculitis associated with rheumatoid arthritis: a case-control study","volume":"53","author":"Makol A","year":"2014","unstructured":"Makol A, Crowson CS, Wetter DA, Sokumbi O, Matteson EL, Warrington KJ. Vasculitis associated with rheumatoid arthritis: a case-control study. Rheumatology (Oxford). 2014, 53:890-9. 10.1093\/rheumatology\/ket475","journal-title":"Rheumatology (Oxford)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3109\/03009742.2014.923931","article-title":"Clinical and biological differences between cryoglobulinaemic and hypergammaglobulinaemic purpura in primary Sj\u00f6gren's syndrome: results of a large multicentre study","volume":"44","author":"Quartuccio L","year":"2015","unstructured":"Quartuccio L, Isola M, Baldini C, et al.. Clinical and biological differences between cryoglobulinaemic and hypergammaglobulinaemic purpura in primary Sj\u00f6gren's syndrome: results of a large multicentre study. Scand J Rheumatol. 2015, 44:36-41. 10.3109\/03009742.2014.923931","journal-title":"Scand J Rheumatol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2020.07.013","article-title":"Cryoglobulinemic vasculitis in primary Sj\u00f6gren's syndrome: clinical presentation, association with lymphoma and comparison with Hepatitis C-related disease","volume":"50","author":"Argyropoulou OD","year":"2020","unstructured":"Argyropoulou OD, Pezoulas V, Chatzis L, et al.. Cryoglobulinemic vasculitis in primary Sj\u00f6gren's syndrome: clinical presentation, association with lymphoma and comparison with Hepatitis C-related disease. Semin Arthritis Rheum. 2020, 50:846-53. 10.1016\/j.semarthrit.2020.07.013","journal-title":"Semin Arthritis Rheum"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-008-9214-3","article-title":"Impact of three anti-TNFalpha biologics on existing and emergent autoimmunity in rheumatoid arthritis and spondylarthropathy patients","volume":"28","author":"Bacquet-Deschryver H","year":"2008","unstructured":"Bacquet-Deschryver H, Jouen F, Quillard M, et al.. Impact of three anti-TNFalpha biologics on existing and emergent autoimmunity in rheumatoid arthritis and spondylarthropathy patients. J Clin Immunol. 2008, 28:445-55. 10.1007\/s10875-008-9214-3","journal-title":"J Clin Immunol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.lpm.2020.104033","article-title":"Management of cutaneous vasculitis","volume":"49","author":"Micheletti RG","year":"2020","unstructured":"Micheletti RG, Pagnoux C. Management of cutaneous vasculitis. Presse Med. 2020, 49:104033. 10.1016\/j.lpm.2020.104033","journal-title":"Presse Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/523319-etanercept-induced-cutaneous-necrotizing-vasculitis-in-a-patient-with-rheumatoid-arthritis-a-case-report-and-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T17:15:45Z","timestamp":1789838145000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/523319-etanercept-induced-cutaneous-necrotizing-vasculitis-in-a-patient-with-rheumatoid-arthritis-a-case-report-and-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,19]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.116548","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,19]]}}}